Related Experiment Videos
Epstein-Barr virus and systemic lupus erythematosus
Judith A James1, John B Harley, R Hal Scofield
1Arthritis and Immunology, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. jamesj@omrf.ouhsc.edu
Current Opinion in Rheumatology
|August 10, 2006
Summary
Epstein-Barr virus (EBV) plays a significant role in systemic lupus erythematosus (SLE). Research shows EBV differences in SLE patients, including viral load and immune responses, impacting disease understanding.
Area of Science:
- Immunology
- Virology
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multifactorial origins.
- Genetic and environmental factors are implicated, but the specific role of infectious agents like Epstein-Barr virus (EBV) is under investigation.
Purpose of the Study:
- To review evolving evidence on the specific roles of Epstein-Barr virus in systemic lupus erythematosus.
- To highlight recent findings linking EBV to lupus autoimmunity and immune system differences.
Main Methods:
- Review of recent molecular mimicry studies.
- Analysis of data on EBV viral load, B cell infection, and T cell responses.
- Examination of EBV serology and humoral immune responses in SLE patients.
Main Results:
- Evidence suggests molecular mimicry mechanisms between early lupus autoimmunity and EBV responses.
- Increased EBV viral load and infected B cells are observed in SLE patients.
- Impaired T cell responses and distinct humoral immune responses to EBV antigens are noted in SLE.
Conclusions:
- Recent advances support significant differences in EBV-related markers between SLE patients and controls.
- These findings enhance the understanding of Epstein-Barr virus's impact on systemic lupus erythematosus pathogenesis.